Large B-Cell Lymphoma With IRF4 Rearrangement
3 clinical trials · Condition
◉ Watch Large B-Cell Lymphoma With IRF4 Rearrangement
| Record | Firm | Date |
|---|---|---|
| Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma (NCT05202782) | Northwestern University | 2022-03-21 |
| Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672) | National Cancer Institute (NCI) | 2018-12-21 |
Track Large B-Cell Lymphoma With IRF4 Rearrangement automatically
Every clearance here is in the API, with alerts when new ones post.